Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
Español
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Treatment of paroxysmal nonkinesigenic dyskinesia
Zain Guduru
, Kapil D. Sethi
Neurology
Neuroscience Research Priority Area
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of paroxysmal nonkinesigenic dyskinesia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Dyskinesia
100%
Combination Therapy
50%
Cohort Effect
50%
Gene Mutation
50%
Stereotypic Movement Disorder
50%
Autosomal Dominant Inheritance
50%
Carbamazepine
50%
Loss of Consciousness
50%
Benzatropine
50%
Involuntary Movement
50%
Clonazepam
50%
Deep Brain Stimulation
50%
Chromosome 2q
50%
Neuroscience
Dyskinesia
100%
Carbamazepine
50%
Deep Brain Stimulation
50%
Gene Mutation
50%
Stereotypic Movement Disorder
50%
Clonazepam
50%
Chromosome 2q
50%
Pharmacology, Toxicology and Pharmaceutical Science
Dyskinesia
100%
Clonazepam
50%
Motor Dysfunction
50%
Carbamazepine
50%
Benzatropine
50%
Combination Therapy
50%